AI
DRTS icon

Atom Investors’s Alpha Tau Medical DRTS Stock Holding History

Atom Investors’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,773
Closed -$80.4K – 661
2025
Q2 		$80.4K Buy
25,773
+3,508
+16% +$9.88K 0.01% 563
2025
Q1 		$55.9K Buy
+22,265
New +$69.8K 0.01% 465

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Atom Investors's DRTS Position: Q3 2025 in Review

Atom Investors sold out of Alpha Tau Medical (DRTS) in Q3 2025, closing a stake of 25,773 shares — an estimated $80.4K sold.

Atom Investors first reported a position in DRTS in Q1 2025 and held it in 2 quarters. The position peaked at $80.4K in Q2 2025. 31 funds tracked by Wall St. Rank hold DRTS as of Q3 2025.

  • Atom Investors reported no remaining Alpha Tau Medical position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 25,773 Alpha Tau Medical shares in Q3 2025, an estimated $80.4K.
  • Atom Investors first reported a position in Alpha Tau Medical in Q1 2025 and held it in 2 quarters.
  • Atom Investors's Alpha Tau Medical position peaked at $80.4K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.